Mesa Laboratories Stock Performance
| MLAB Stock | USD 79.77 1.14 1.45% |
Mesa Laboratories has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.69, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesa Laboratories will likely underperform. Mesa Laboratories right now secures a risk of 3.09%. Please verify Mesa Laboratories treynor ratio, downside variance, kurtosis, as well as the relationship between the value at risk and expected short fall , to decide if Mesa Laboratories will be following its current price movements.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Mesa Laboratories are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat inconsistent basic indicators, Mesa Laboratories may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
Actual Historical Performance (%)
One Day Return 1.45 | Five Day Return 1.24 | Year To Date Return (39.55) | Ten Year Return (19.10) | All Time Return 2.6 K |
Forward Dividend Yield 0.0081 | Payout Ratio | Forward Dividend Rate 0.64 | Dividend Date 2025-12-15 | Ex Dividend Date 2025-11-28 |
1 | AlphaQuest LLC Has 571,000 Stock Holdings in Mesa Laboratories, Inc. MLAB - MarketBeat | 10/29/2025 |
2 | Mesa Labs earnings beat by 0.45, revenue topped estimates - Investing.com | 11/06/2025 |
3 | Mesa Laboratories Has Announced A Dividend Of 0.16 | 11/07/2025 |
4 | Will Mesa Laboratories Inc. stock remain on Wall Street radar - Earnings Miss AI Driven Stock Price Forecasts - newser.com | 11/13/2025 |
5 | How Mesa Laboratories Inc. stock reacts to Fed tightening - July 2025 Momentum Stepwise EntryExit Trade Alerts - newser.com | 11/19/2025 |
6 | Heres Why Mesa Laboratories Can Manage Its Debt Responsibly | 11/26/2025 |
7 | Disposition of 2000 shares by Sullivan John James of Mesa Laboratories subject to Rule 16b-3 | 12/02/2025 |
8 | Mesa Laboratories, Inc. to Release Third Quarter Financial Results for Fiscal Year 2026 on February 3, 2026 - Quiver Quantitative | 12/03/2025 |
| Mesa Laboratories dividend paid on 15th of December 2025 | 12/15/2025 |
| Begin Period Cash Flow | 28.2 M | |
| Total Cashflows From Investing Activities | -4.5 M |
Mesa Laboratories Relative Risk vs. Return Landscape
If you would invest 7,299 in Mesa Laboratories on September 19, 2025 and sell it today you would earn a total of 678.00 from holding Mesa Laboratories or generate 9.29% return on investment over 90 days. Mesa Laboratories is currently generating 0.1877% in daily expected returns and assumes 3.092% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than Mesa, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mesa Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesa Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mesa Laboratories, and traders can use it to determine the average amount a Mesa Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0607
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MLAB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Mesa Laboratories is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mesa Laboratories by adding it to a well-diversified portfolio.
Mesa Laboratories Fundamentals Growth
Mesa Stock prices reflect investors' perceptions of the future prospects and financial health of Mesa Laboratories, and Mesa Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mesa Stock performance.
| Return On Equity | -0.0093 | ||||
| Return On Asset | 0.0213 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 604.23 M | ||||
| Shares Outstanding | 5.52 M | ||||
| Price To Earning | 433.94 X | ||||
| Price To Book | 2.41 X | ||||
| Price To Sales | 1.77 X | ||||
| Revenue | 240.98 M | ||||
| Gross Profit | 152.44 M | ||||
| EBITDA | 42.35 M | ||||
| Net Income | (1.97 M) | ||||
| Cash And Equivalents | 43.75 M | ||||
| Cash Per Share | 8.23 X | ||||
| Total Debt | 181.47 M | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 2.90 X | ||||
| Book Value Per Share | 32.38 X | ||||
| Cash Flow From Operations | 46.81 M | ||||
| Earnings Per Share | (0.31) X | ||||
| Market Capitalization | 434.22 M | ||||
| Total Asset | 433.35 M | ||||
| Retained Earnings | (188.94 M) | ||||
| Working Capital | (61.28 M) | ||||
| Current Asset | 10.74 M | ||||
| Current Liabilities | 657 K | ||||
About Mesa Laboratories Performance
By analyzing Mesa Laboratories' fundamental ratios, stakeholders can gain valuable insights into Mesa Laboratories' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mesa Laboratories has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mesa Laboratories has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 102.75 | 97.61 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Equity | (0.01) | (0.01) |
Things to note about Mesa Laboratories performance evaluation
Checking the ongoing alerts about Mesa Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mesa Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mesa Laboratories had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 240.98 M. Net Loss for the year was (1.97 M) with profit before overhead, payroll, taxes, and interest of 152.44 M. | |
| Over 93.0% of the company shares are owned by institutional investors | |
| On 15th of December 2025 Mesa Laboratories paid $ 0.16 per share dividend to its current shareholders | |
| Latest headline from news.google.com: Mesa Laboratories, Inc. to Release Third Quarter Financial Results for Fiscal Year 2026 on February 3, 2026 - Quiver Quantitative |
- Analyzing Mesa Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mesa Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Mesa Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mesa Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mesa Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mesa Laboratories' stock. These opinions can provide insight into Mesa Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mesa Stock analysis
When running Mesa Laboratories' price analysis, check to measure Mesa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mesa Laboratories is operating at the current time. Most of Mesa Laboratories' value examination focuses on studying past and present price action to predict the probability of Mesa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mesa Laboratories' price. Additionally, you may evaluate how the addition of Mesa Laboratories to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |